SCHEMBL4776294

SCHEMBL4776294

COC(=O)C(=O)ONN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144851 0.87 CYP1A2 (0.35)
SCHEMBL6950834 0.77 ALDH1A1 (0.56)
SCHEMBL8295 0.77
SCHEMBL15845571 0.77
SCHEMBL16279760 0.74 TSHR (0.37)
Urea SCHEMBL11495730 0.74 ALDH1A1 (0.47)
Methyl Alcohol SCHEMBL15233825 0.73 ALDH1A1 (0.53)
SCHEMBL28352291 0.73
SCHEMBL28824476 0.73
SCHEMBL28791576 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022259210-A1 NOVEL PROCESS FOR PREPARATION OF 1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-OL INCOR RENOVIS PHARMA PRIVATE LIMITED (IN) 2022-12-15 WO claimed
WO-2022259210-A1 NOVEL PROCESS FOR PREPARATION OF 1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-OL INCOR RENOVIS PHARMA PRIVATE LIMITED (IN) 2022-12-15 WO disclosed
EP-1907372-A1 SUBSTITUTED CYCLOHEXYL DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS MERCK SHARP &amp; DOHME LTD. (GB) 2008-04-09 EP disclosed
WO-2007003965-A1 SUBSTITUTED CYCLOHEXYL DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 2007-01-11 WO disclosed